These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 523796)

  • 41. Correction of renal hypertension in the rat by prolonged infusion of angiotensin inhibitors.
    Riegger AJ; Lever AF; Millar JA; Morton JJ; Slack B
    Lancet; 1977 Dec 24-31; 2(8052-8053):1317-9. PubMed ID: 74729
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hemodynamic effects of sar1-ala8-angiotensin in patients with renovascular hypertension (author's transl)].
    Philipp T; Zschierdrich H; Distler A
    Klin Wochenschr; 1977 Sep; 55(18):917-9. PubMed ID: 916618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sodium and renin in the hypertension of early renal disease.
    Wong SF; Mitchell MI; Robson V; Wilkinson R
    Clin Sci Mol Med Suppl; 1978 Dec; 4():301s-303s. PubMed ID: 282072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renin--angiotensin antagonists and the regulation of blood pressure.
    Samuels AI; Miller ED; Fray JC; Haber E; Barger AC
    Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypotensive effect of [Sar1,Thr8]angiotensin II in spontaneously hypertensive sodium-depleted rats.
    Muñoz-Ramírez H; Khosla MC; Bumpus FM; Khairallah PA
    Am J Physiol; 1978 Apr; 234(4):H447-53. PubMed ID: 645884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sympathetic and renin-angiotensin system influence on blood pressure and renal blood flow of two-kidney, one clip Goldblatt hypertensive dog.
    Zimmerman BG; Mommsen C; Kraft E
    Hypertension; 1980; 2(1):53-62. PubMed ID: 6989757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exchangeable sodium in angiotensinogenic and nonangiotensinogenic renovascular hypertension.
    Albertini R; Binia A; Otsuka Y; Carretero OA
    Hypertension; 1979; 1(6):624-30. PubMed ID: 232088
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of saralasin on plasma renin activity and arginine-vasopressin in hypertensive man.
    Arlart IP; Rosenthal J; Wagner H; Franz HE
    Proc Eur Dial Transplant Assoc; 1978; 15():412-7. PubMed ID: 740674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angiotensin II is a necessary component for the development of hypertension in the two kidney, one clip rat.
    DeForrest JM; Knappenberger RC; Antonaccio MJ; Ferrone RA; Creekmore JS
    Am J Cardiol; 1982 Apr; 49(6):1515-7. PubMed ID: 6280481
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence and pathophysiological changes in chronic two-kidney hypertension in the dog.
    Watkins BE; Davis JO; Hanson RC; Lohmeier TE; Freeman RH
    Am J Physiol; 1976 Sep; 231(3):954-60. PubMed ID: 970479
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients.
    Case DB; Wallace JM; Keim HJ; Sealey JE; Laragh JH
    Am J Med; 1976 May; 60(6):825-36. PubMed ID: 1020762
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Saralasin test, renal vein renin and unilateral kidney blood flow in renovascular hypertension].
    Helber A; Hummerich W; Bönner G; Meurer KA; Moritz G
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():208-9. PubMed ID: 613575
    [No Abstract]   [Full Text] [Related]  

  • 53. Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension.
    Marks LS; Maxwell MH; Kaufman JJ
    Ann Intern Med; 1977 Aug; 87(2):176-82. PubMed ID: 889198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade.
    Camargo MJ; von Lutterotti N; Campbell WG; Pecker MS; James GD; Timmermans PB; Laragh JH
    J Hypertens; 1993 Jan; 11(1):31-40. PubMed ID: 8382237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of a high renin model of hypertension in the cynomolgus monkey.
    Panek RL; Ryan MJ; Weishaar RE; Taylor DG
    Clin Exp Hypertens A; 1991; 13(8):1395-414. PubMed ID: 1760894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Responsiveness to pressor agents in experimental renovascular and steroid hypertension. Effects of converting enzyme inhibitor and nephrectomy.
    Marks ES; Bing RF; Thurston H; Russell GI; Swales JD
    Hypertension; 1982; 4(2):238-44. PubMed ID: 6279494
    [No Abstract]   [Full Text] [Related]  

  • 57. Antihypertensive and aldosterone-lowering effects of synthetic atrial natriuretic factor in renin-dependent renovascular hypertension.
    Volpe M; Odell G; Kleinert HD; Camargot MJ; Laragh JH; Lewicki JA; Maack T; Vaughan ED; Atlas SA
    J Hypertens Suppl; 1984 Dec; 2(3):S313-5. PubMed ID: 6242558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiotensin II blockade in hypertensive dialysis patients.
    MacGregor GA; Dawes PM
    Prog Biochem Pharmacol; 1976; 12():190-9. PubMed ID: 1019164
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.
    Anderson GH; Streeten DH; Dalakos TG
    Circ Res; 1977 Mar; 40(3):243-50. PubMed ID: 837471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of indomethacin on blood pressure in rats with renovascular hypertension: dependence on plasma renin activity.
    Stahl R; Dienemann H; Besserer K; Kneissler U; Helmchen U
    Klin Wochenschr; 1981 Mar; 59(5):245-6. PubMed ID: 7012436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.